Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:18840986rdf:typepubmed:Citationlld:pubmed
pubmed-article:18840986lifeskim:mentionsumls-concept:C0087111lld:lifeskim
pubmed-article:18840986lifeskim:mentionsumls-concept:C0546837lld:lifeskim
pubmed-article:18840986lifeskim:mentionsumls-concept:C0019004lld:lifeskim
pubmed-article:18840986lifeskim:mentionsumls-concept:C0022661lld:lifeskim
pubmed-article:18840986lifeskim:mentionsumls-concept:C0016360lld:lifeskim
pubmed-article:18840986lifeskim:mentionsumls-concept:C0851346lld:lifeskim
pubmed-article:18840986lifeskim:mentionsumls-concept:C0205195lld:lifeskim
pubmed-article:18840986lifeskim:mentionsumls-concept:C1533148lld:lifeskim
pubmed-article:18840986lifeskim:mentionsumls-concept:C0332293lld:lifeskim
pubmed-article:18840986lifeskim:mentionsumls-concept:C0231242lld:lifeskim
pubmed-article:18840986lifeskim:mentionsumls-concept:C0205179lld:lifeskim
pubmed-article:18840986pubmed:issue10lld:pubmed
pubmed-article:18840986pubmed:dateCreated2008-10-8lld:pubmed
pubmed-article:18840986pubmed:abstractText5-Fluorouracil(5-FU)and cis-dichlorodiammineplatinum(CDDP)combined with 60Gy of radiation was administered to a 65-year-old man with advanced esophageal cancer complicated with chronic renal failure treated with hemodialysis(HD). Continuous infusion of 5-FU 680mg/m(2) on Days 1-5 and 8-12, and drip infusion of CDDP 40mg/m(2) on Days 1 and 8 were administered twice with a 5-week interval. The CDDP dosage was reduced to 40% and HD was started 30 minutes after CDDP administration. Concurrent radiotherapy was started on Day 1 at 2Gy/d for 5d/week. The concentration of both free CDDP and total CDDP was measured using the atomic absorption method after the second treatment period. The area under the curve(AUC)of free CDDP was 3.3microg x h/ml. Both Grade 4 anemia and Grade 3 leukopenia were observed, but the renal failure did not progress. All toxicities were tolerable and the CDDP dose reduction and HD method were appropriate for the patient.lld:pubmed
pubmed-article:18840986pubmed:languagejpnlld:pubmed
pubmed-article:18840986pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:18840986pubmed:citationSubsetIMlld:pubmed
pubmed-article:18840986pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:18840986pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:18840986pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:18840986pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:18840986pubmed:statusMEDLINElld:pubmed
pubmed-article:18840986pubmed:monthOctlld:pubmed
pubmed-article:18840986pubmed:issn0446-6586lld:pubmed
pubmed-article:18840986pubmed:authorpubmed-author:AraiYokoYlld:pubmed
pubmed-article:18840986pubmed:authorpubmed-author:MiyataYoshino...lld:pubmed
pubmed-article:18840986pubmed:authorpubmed-author:OyamaTsuneoTlld:pubmed
pubmed-article:18840986pubmed:authorpubmed-author:TomoriAkihisa...lld:pubmed
pubmed-article:18840986pubmed:authorpubmed-author:HottaKinichiKlld:pubmed
pubmed-article:18840986pubmed:issnTypePrintlld:pubmed
pubmed-article:18840986pubmed:volume105lld:pubmed
pubmed-article:18840986pubmed:ownerNLMlld:pubmed
pubmed-article:18840986pubmed:authorsCompleteYlld:pubmed
pubmed-article:18840986pubmed:pagination1482-8lld:pubmed
pubmed-article:18840986pubmed:dateRevised2011-8-2lld:pubmed
pubmed-article:18840986pubmed:meshHeadingpubmed-meshheading:18840986...lld:pubmed
pubmed-article:18840986pubmed:meshHeadingpubmed-meshheading:18840986...lld:pubmed
pubmed-article:18840986pubmed:meshHeadingpubmed-meshheading:18840986...lld:pubmed
pubmed-article:18840986pubmed:meshHeadingpubmed-meshheading:18840986...lld:pubmed
pubmed-article:18840986pubmed:meshHeadingpubmed-meshheading:18840986...lld:pubmed
pubmed-article:18840986pubmed:meshHeadingpubmed-meshheading:18840986...lld:pubmed
pubmed-article:18840986pubmed:meshHeadingpubmed-meshheading:18840986...lld:pubmed
pubmed-article:18840986pubmed:meshHeadingpubmed-meshheading:18840986...lld:pubmed
pubmed-article:18840986pubmed:meshHeadingpubmed-meshheading:18840986...lld:pubmed
pubmed-article:18840986pubmed:meshHeadingpubmed-meshheading:18840986...lld:pubmed
pubmed-article:18840986pubmed:meshHeadingpubmed-meshheading:18840986...lld:pubmed
pubmed-article:18840986pubmed:meshHeadingpubmed-meshheading:18840986...lld:pubmed
pubmed-article:18840986pubmed:meshHeadingpubmed-meshheading:18840986...lld:pubmed
pubmed-article:18840986pubmed:meshHeadingpubmed-meshheading:18840986...lld:pubmed
pubmed-article:18840986pubmed:year2008lld:pubmed
pubmed-article:18840986pubmed:articleTitle[Successful treatment with 5-fluorouracil and cis-dichlorodiammineplatinum combined with 60Gy of radiation in a case of advanced esophageal cancer complicated with chronic renal failure treated with hemodialysis].lld:pubmed
pubmed-article:18840986pubmed:affiliationDepartment of Gastroenterology, Saku Central Hospital.lld:pubmed
pubmed-article:18840986pubmed:publicationTypeJournal Articlelld:pubmed
pubmed-article:18840986pubmed:publicationTypeEnglish Abstractlld:pubmed
pubmed-article:18840986pubmed:publicationTypeCase Reportslld:pubmed